NCT04595903View on ClinicalTrials.gov

Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

November 14, 2022

Study Completion Date

November 14, 2022

Conditions
COVID-19
Interventions
DEVICE

Hemopurifier

Hemopurifier treatments will be one four to six hour treatment session daily for up to 4 days

Trial Locations (9)

19107

Thomas Jefferson University Hospital, Philadelphia

33136

University of Miami Hospital, Miami

71103

LSU Health Sciences Center, Shreveport

78550

Valley Baptist Medical Center, Harlingen

92354

Loma Linda University Medical Center, Loma Linda

92618

Hoag Hospital - Irvine, Irvine

92663

Hoag Memorial Hospital Presbyterian, Newport Beach

95817

UC Davis Health System, Sacramento

08103

Cooper University Hospital, Camden

Sponsors
All Listed Sponsors
lead

Aethlon Medical Inc.

INDUSTRY